Detalhe da pesquisa
1.
18F-Sodium fluoride PET/CT predicts overall survival in patients with advanced genitourinary malignancies treated with cabozantinib and nivolumab with or without ipilimumab.
Eur J Nucl Med Mol Imaging
; 47(1): 178-184, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31522271
2.
Cabozantinib plus Nivolumab Phase I Expansion Study in Patients with Metastatic Urothelial Carcinoma Refractory to Immune Checkpoint Inhibitor Therapy.
Clin Cancer Res
; 28(7): 1353-1362, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35031545
3.
Circulating Tumor Cell Subtypes and T-cell Populations as Prognostic Biomarkers to Combination Immunotherapy in Patients with Metastatic Genitourinary Cancer.
Clin Cancer Res
; 27(5): 1391-1398, 2021 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33262136
4.
Phase I Study of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced or Metastatic Urothelial Carcinoma and Other Genitourinary Tumors.
J Clin Oncol
; 38(31): 3672-3684, 2020 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32915679